sábado, 14 de novembro de 2026
PesquisarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· January 28, 2026

eSim Market Analysis Report 2025: A $35.7 Billion Market by 2033 Featuring AT&T, IDEMIA, Giesecke+Devrient, Infineon Technologies, Kigen, KORE Wireless, STMicroelectronics, Thales, Trasna, Valid

View original at finance.yahoo.com
“The eSIM market is projected to surge from USD 11.74 billion in 2025 to USD 35.7 billion by 2033, experiencing a CAGR of 14.91%.”
Verbatim excerpt from the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Growth is fueled by rising connectivity needs, IoT adoption, and embedded SIM tech in sectors like consumer electronics and automotive.

    80% confidence
  • The proliferation of 5G networks and the push for digital connectivity are further accelerating the eSIM market.

    80% confidence
  • The continued integration of eSIMs into 5G-enabled devices and smart ecosystems will further enhance connectivity, positioning the technology as a cornerstone of future global communication infrastructure.

    80% confidence
  • A major challenge in the eSIM market is achieving full interoperability across different devices, carriers, and regions, with global standards established by organizations like GSMA not universally implemented.

    80% confidence
  • Remote provisioning, if not properly secured, can expose networks to cyber threats, unauthorized access, or data breaches.

    80% confidence
  • The eSIM market is projected to surge from USD 11.74 billion in 2025 to USD 35.7 billion by 2033, experiencing a CAGR of 14.91%.

    80% confidence
  • The eSIM industry is set to achieve sustained growth, supported by technological innovation, increasing consumer digitalization, and expanding use cases across industries such as automotive, healthcare, logistics, and consumer electronics.

    80% confidence
  • The ongoing deployment of 5G networks worldwide has accelerated the adoption of eSIM technology, with eSIMs complementing 5G's high-speed, low-latency connectivity.

    80% confidence
  • Challenges remain with compatibility and regulatory issues in the eSIM market.

    80% confidence
  • Regional markets in the U.S., UK, China, and UAE show promising advancements in eSIM technology.

    80% confidence
  • The rapid growth of the IoT ecosystem is a key driver of the eSIM market, with billions of devices requiring seamless connectivity.

    80% confidence
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
A nossa leitura dos dados ›
Sinais que acompanhamos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Padrões que observamos ›
Onde as fontes divergem
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,995
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,995 factos verificados com a fonte5,577 documentos-fonte arquivados
Consulte estes dados → isubstrate.com